Private Wealth Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Private Wealth Asset Management's BMY Position: Q1 2026 in Review
Private Wealth Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.3% in Q1 2026, buying an estimated $22.7K and bringing the position to 17,470 shares worth $1.06M. The position accounts for 0.11% of the portfolio, ranked #122.
Private Wealth Asset Management first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.38M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Private Wealth Asset Management held 17,470 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
- Private Wealth Asset Management bought 390 Bristol-Myers Squibb shares in Q1 2026, an estimated $22.7K.
- Bristol-Myers Squibb made up 0.11% of Private Wealth Asset Management's portfolio in Q1 2026, its #122 holding.
- Private Wealth Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- Private Wealth Asset Management's Bristol-Myers Squibb position peaked at $1.38M in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Private Wealth Asset Management's 13F filing for Q1 2026, filed 6 May 2026.